ISOLOGIC invests $29.9M to expand and modernize Lachine radiopharmaceutical site

ISOLOGIC Radiopharmaceutiques Novateurs announced a $29.9M investment to expand and modernize its Lachine site, including a new cyclotron operational by Q1 2026, to secure supply of PET radioisotopes.

“ISOLOGIC Radiopharmaceutiques Novateurs annonce l'investissement de 29,9 millions $ afin de soutenir l'évolution du secteur des produits pharmaceutiques.”newswire.ca

• 1 source
• newswire.caInvestissement majeur de 29,9 millions $ d'ISOLOGIC au QuébecISOLOGIC Radiopharmaceutiques NovateursJun 4, 2024

Summarized from public sources; check the original articles before acting on it.